Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03454451 |
|---|---|
| Brief Title: | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers |
| First Submitted : | February 5, 2018 |
| First Submitted that Met QC Criteria : | March 2, 2018 |
| First Posted : | March 6, 2018 |
| Last Update Submitted that Met QC Criteria : | December 19, 2023 |
| Last Update Posted : | December 21, 2023 |